Last update 25 Apr 2026

Dextromethorphan Hydrobromide Hydrate/EXV-801

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Dextromethorphan + EXV-801, EXV-802
Target
NMDA receptor x σ1 receptor
Action
antagonists, agonists
Mechanism
NMDA receptor antagonists(Glutamate [NMDA] receptor antagonists), σ1 receptor agonists(Sigma opioid receptor agonists)
Therapeutic Areas
Nervous System DiseasesOther Diseases
Active Indication
AgitationAlzheimer Disease
Inactive Indication-
Originator Organization
Exciva GmbHExciva GmbH
Active Organization
Exciva GmbHExciva GmbH
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2/3
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Dextromethorphan Hydrobromide Hydrate/EXV-801
NCT07284472
/ RecruitingPhase 2/3
Phase 2/3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Participants With Alzheimer's Disease Dementia
100 Clinical Results associated with Dextromethorphan Hydrobromide Hydrate/EXV-801
Login to view more data
100 Translational Medicine associated with Dextromethorphan Hydrobromide Hydrate/EXV-801
Login to view more data
100 Patents (Medical) associated with Dextromethorphan Hydrobromide Hydrate/EXV-801
Login to view more data
100 Deals associated with Dextromethorphan Hydrobromide Hydrate/EXV-801
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
AgitationPhase 3
United States
Exciva GmbHExciva GmbH
02 Feb 2026
AgitationPhase 3
Canada
Exciva GmbHExciva GmbH
02 Feb 2026
AgitationPhase 3
United Kingdom
Exciva GmbHExciva GmbH
02 Feb 2026
Alzheimer DiseasePhase 3
United States
Exciva GmbHExciva GmbH
02 Feb 2026
Alzheimer DiseasePhase 3
Canada
Exciva GmbHExciva GmbH
02 Feb 2026
Alzheimer DiseasePhase 3
United Kingdom
Exciva GmbHExciva GmbH
02 Feb 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free